SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 41 filers reported holding SOLENO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $90,000 | -5.3% | 488,393 | +13.5% | 0.00% | – |
| Q1 2022 | $95,000 | -46.0% | 430,253 | 0.0% | 0.00% | – |
| Q4 2021 | $176,000 | -55.7% | 430,253 | 0.0% | 0.00% | – |
| Q3 2021 | $397,000 | -15.4% | 430,253 | +4.4% | 0.00% | – |
| Q2 2021 | $469,000 | -55.0% | 412,068 | -50.2% | 0.00% | – |
| Q1 2021 | $1,042,000 | -24.9% | 827,746 | +15.0% | 0.00% | – |
| Q4 2020 | $1,388,000 | -2.5% | 719,512 | +26.9% | 0.00% | – |
| Q3 2020 | $1,423,000 | +74.4% | 567,008 | +54.1% | 0.00% | – |
| Q2 2020 | $816,000 | +145.0% | 367,876 | +162.5% | 0.00% | – |
| Q1 2020 | $333,000 | -0.3% | 140,165 | +23.2% | 0.00% | – |
| Q4 2019 | $334,000 | +542.3% | 113,798 | +224.2% | 0.00% | – |
| Q3 2019 | $52,000 | -46.9% | 35,097 | 0.0% | 0.00% | – |
| Q2 2019 | $98,000 | +66.1% | 35,097 | +20.9% | 0.00% | – |
| Q1 2019 | $59,000 | -39.8% | 29,035 | -50.0% | 0.00% | – |
| Q4 2018 | $98,000 | +58.1% | 58,070 | +100.0% | 0.00% | – |
| Q3 2018 | $62,000 | – | 29,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $9,500,000 | 2.16% |
| Nantahala Capital Management | 9,765,129 | $9,028,000 | 0.28% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,132,000 | $1,971,000 | 0.24% |
| Granite Point Capital Management, L.P. | 701,838 | $649,000 | 0.05% |
| OPPENHEIMER & CO INC | 639,140 | $591,000 | 0.01% |
| Ikarian Capital, LLC | 121,694 | $112,000 | 0.01% |
| Warberg Asset Management LLC | 30,000 | $28,000 | 0.01% |
| Levy Wealth Management Group, LLC | 10,000 | $9,000 | 0.01% |
| Ergoteles LLC | 74,525 | $69,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 744,000 | $688,000 | 0.00% |